Zomedica Pharmaceuticals Corp (ZOM) - Total Liabilities

Latest as of March 2025: $10.55 Million USD

Based on the latest financial reports, Zomedica Pharmaceuticals Corp (ZOM) has total liabilities worth $10.55 Million USD as of March 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Zomedica Pharmaceuticals Corp (ZOM) cash conversion ratio to assess how effectively this company generates cash.

Zomedica Pharmaceuticals Corp - Total Liabilities Trend (2012–2024)

This chart illustrates how Zomedica Pharmaceuticals Corp's total liabilities have evolved over time, based on quarterly financial data. Check Zomedica Pharmaceuticals Corp liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Zomedica Pharmaceuticals Corp Competitors by Total Liabilities

The table below lists competitors of Zomedica Pharmaceuticals Corp ranked by their total liabilities.

Company	Country	Total Liabilities
Defiance Silver Corp V:DEF	Canada	CA$720.25K
SK Innovation Co Ltd Pref KO:096775	Korea	₩69.10 Trillion
Pansari Developers Limited NSE:PANSARI	India	Rs1.41 Billion
INTER RAO Lietuva AB WAR:IRL	Poland	zł41.78 Million
A-Tech Solution Co. Ltd KQ:071670	Korea	₩221.67 Billion
R K Swamy Limited NSE:RKSWAMY	India	Rs1.50 Billion
Prestige Wealth Inc. NASDAQ:AURE	USA	$42.54 Million

Liability Composition Analysis (2012–2024)

This chart breaks down Zomedica Pharmaceuticals Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Zomedica Pharmaceuticals Corp (ZOM) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	9.89	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.08	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.07	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Zomedica Pharmaceuticals Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Zomedica Pharmaceuticals Corp (2012–2024)

The table below shows the annual total liabilities of Zomedica Pharmaceuticals Corp from 2012 to 2024.

Year	Total Liabilities	Change
2024-12-31	$11.70 Million	-11.26%
2023-12-31	$13.18 Million	+7.87%
2022-12-31	$12.22 Million	+28.42%
2021-12-31	$9.51 Million	-36.90%
2020-12-31	$15.08 Million	+622.30%
2019-12-31	$2.09 Million	-12.16%
2018-12-31	$2.38 Million	+186.76%
2017-12-31	$828.74K	+11.82%
2016-12-31	$741.16K	+406.64%
2015-12-31	$146.29K	+3620.99%
2014-12-31	$3.93K	-23.76%
2013-12-31	$5.16K	+427.95%
2012-12-31	$976.80	--

About Zomedica Pharmaceuticals Corp

NYSE MKT:ZOM USA Medical Devices

Market Cap

$53.90 Million

Market Cap Rank

#21714 Global

#4712 in USA

Share Price

$0.06

Change (1 day)

+0.00%

52-Week Range

$0.06 - $0.06

All Time High

$2.98